Virta Health, recognized as a pioneer in diabetes reversal and sustainable weight loss through a nutrition-centric model, has reported unprecedented growth exceeding 60% year-over-year, achieving over $100 million in annual revenue. This surge is largely fueled by the rising interest in its Sustainable Weight Loss (SWL) program, which has recently been enhanced to incorporate 'Responsible Prescribing' features. Additionally, the ongoing expansion of its diabetes reversal services has contributed to Virta's success, as the company partners with over 550 organizations, impacting more than 12 million lives across the United States.
As the obesity epidemic garners increasing focus and the use of GLP-1 medications rises, the demand for Virta's nutrition-centric method for reversing diabetes and obesity has surged. This is especially relevant considering the challenges of low adherence and the high expense associated with GLP-1 treatments. In response, Virta has introduced Responsible Prescribing, an enhancement to its SWL suite, aimed at assisting employers, health plans, and pharmacy benefit managers in achieving optimal results, whether or not GLP-1 medications are utilized. With this initiative, Virta now offers a drug-free option, combination therapies, and a pathway for transitioning off GLP-1s.
Virta's strategy offers payers the most economical solutions for sustainable health enhancement, incorporating weight loss medications only when necessary. Additionally, its value-based care framework ensures that fees are entirely contingent upon achieving weight loss results and certain savings on medication costs.
With Responsible Prescribing, Virta’s care team maximizes the value of GLP-1s, helping members implement lifestyle changes as an alternative to GLP-1s, or as an offramp from these drugs while maintaining weight loss. This offering builds on nearly a decade of experience safely prescribing and deprescribing GLP-1s for members with type 2 diabetes. Virta is the only lifestyle intervention with peer-reviewed results showing sustained weight loss following complete GLP-1 deprescription and 13% average weight loss for one year with nutrition alone.
“By providing Virta’s nutrition-centric solutions, both with and without GLP-1s, we achieved unprecedented and rapid growth in 2024, and we anticipate reaching profitability in the latter half of this year,” stated Sami Inkinen, CEO and co-founder of Virta. “Our initial success stemmed from our unique clinical and economic results in managing type 2 diabetes. Now, we are applying our evidence-based, nutrition-first strategy to tackle the underlying issues of unhealthy weight and obesity, which affect nearly 75% of the American population. Given this vast market opportunity, we believe it’s still very much ‘Day One’ for us.”
Improving Member Experience through an Expanded Care Team and Customized AI Solutions
In order to foster rapid growth, Virta is swiftly expanding its healthcare teams, more than doubling the number of full-time health coaches, doctors, nurses, and various other medical professionals. Additionally, Virta has introduced a range of AI-driven tools designed to assist clinicians and enable members to initiate nutritional changes, attain significant health improvements, and maintain their results.
For instance, Viv, the AI Assistant from Virta, provides immediate and tailored assistance for everyday, non-medical inquiries. Users have the option to reach out to Viv for straightforward questions (such as, “What are my top fast food choices?”) or consult their health coach for more intricate advice (like, “I need additional support from my partner”). Viv is set to be introduced to members progressively over the course of 2025.
These resources enable members to access support whenever they need it, allowing providers to dedicate more time to motivational coaching, emotional assistance, and addressing intricate medical concerns.
Virta CEO Sami Inkinen will address Virta’s growth and the state of GLP-1s at its upcoming Moonshots for Health conference on January 29-30. Register to attend this free virtual event at: https://moonshots.virtahealth.com/
Information on Virta Health:
Virta Health is the leader in diabetes reversal and sustainable weight loss. Through a combination of personalized nutrition, technology, and expert support, Virta empowers members to build longer, healthier lives—while reducing or eliminating the need for medications. Virta partners with the nation’s largest employers, payers, and pharmacy benefit managers to improve the health of their members while reducing costs. Headquartered in Denver, Colorado, Virta’s mission is to reverse diabetes and obesity in one billion people. For more information, visit www.virtahealth.com.
GET IN TOUCH: Judy Huang
KEYWORD: COLORADO, USA, NORTH AMERICA
INDUSTRY KEYWORD: HEALTH TECHNOLOGY DIABETES FITNESS & NUTRITION ARTIFICIAL INTELLIGENCE PHARMACEUTICAL
ORIGIN: Virta Health
Copyright Business Wire 2025.
发布：2025年1月10日 上午09:00 / 结束：2025年1月10日 上午09:00
